Castleview Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
PCM
Castleview Partners's BCAT Position: Q3 2024 in Review
Castleview Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2024, closing a stake of 537 shares — an estimated $8.81K sold.
Castleview Partners first reported a position in BCAT in Q2 2024 and held it in 1 quarter. The position peaked at $8.81K in Q2 2024. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.
- Castleview Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
- Castleview Partners sold 537 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $8.81K.
- Castleview Partners first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and held it in 1 quarter.
- Castleview Partners's BlackRock Capital Allocation Term Trust position peaked at $8.81K in Q2 2024.
- 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.
Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.